Yale University - Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Yale University - Yale Cancer Center has participated in 4 clinical trials with 3 currently active.
Therapeutic areas: Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers.
Sponsors: BioNTech SE, Genmab, Sun Pharma Advanced Research Company Limited.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Yale University - Yale Cancer Center has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale University - Yale Cancer Center has 4 clinical trials on record, with 3 currently active. Their work covers Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers.
Yes — Yale University - Yale Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.